Menu

Making the Rounds

Circular RNA biogenesis occurs when RNA fragments are bent into closed loops of one or more exons and/or introns.

Jul 16, 2017
Catherine Offord

Circular RNAs often form as the pre-mRNA molecule is processed into its final transcript via splicing, in which introns are removed and exons are linked together. Most circular RNAs are thought to be formed by a process called backsplicing, which joins one end of an exon to the other, or to an upstream exon, forming a circle. Researchers have recently published several models—not all of them necessarily mutually exclusive—to explain how different parts of the RNA molecule are brought into close proximity, encouraging backsplicing and turning a linear sequence into circular RNA.

THE SCIENTIST STAFFTHE SCIENTIST STAFFIn a general backsplicing model, proteins assemble to form the spliceosome that processes transcribed RNA. But instead of splicing exons together in a linear sequence, they join the end of one exon to the beginning of the same exon or to an upstream exon. Below are three mechanisms that can drive this backsplicing

INTRON-PAIRING-DRIVEN CIRCULARIZATION

Complementary base pairs formed between long intronic sequences on different parts of the transcript bring together different splice sites on an RNA molecule, promoting backsplicing.

LARIAT-DRIVEN CIRCULARIZATION

Splicing proteins “skip” some exons, creating an exon-containing lariat—a lasso-shaped structure that introns frequently form during standard splicing. This lariat can be excised and formed into a circle while the leftover RNA forms a linear transcript that lacks the skipped exons.

PROTEIN FACTOR–MEDIATED CIRCULARIZATION

RNA-binding proteins (RBPs) such as Quaking bind to sequences on either side of exons and pull these sequences into proximity with each other, forming circles even in transcripts that are normally spliced in a linear fashion.

THE SCIENTIST STAFF

Read the full story.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.